期刊文献+

冠状动脉介入术后强化他汀类药物治疗的意义 被引量:3

下载PDF
导出
摘要 冠状动脉介入术(PCI)围手术期缺血综合征及术后并发症严重影响了患者的预后,甚至增加死亡风险,因此需要寻找一种全身的治疗方案、调整引发急性冠状动脉综合征(ACS)靶点的生物特性及如何改善PCI术后患者围手术期及远期预后已经成为目前心血管领域备受关注的焦点。既往非随机研究显示他汀类药物类药物治疗是PCI术后生存获益的独立预测因子,
出处 《心肺血管病杂志》 CAS 2011年第1期82-84,共3页 Journal of Cardiovascular and Pulmonary Diseases
  • 相关文献

参考文献20

  • 1Cannon CP,Steinberg BA,Mushy SA,et al.Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.J Am Coll Cardiol,2006,48:438-445.
  • 2Expert panel on detection,evaluationg,and treatment of high blood cholesterol in adults.Executive summary of the third report of thenational cholesterol education program(NCEP)expert panel on detection,evaluationg,and treatment of high blood cholesterol in adults(Adult treatment panel Ⅲ).JAMA,2001,285:2486-2497.
  • 3Grundy SM,Cleeman JI,Merz CN,et al.Implications of rccent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guidelines.Circulation,2004,110:227-239.
  • 4Serruys PW,De Feyter PJ,Benghozi R,et al.The Lescol(R)intervention prevention study(UPS):a double-blind,placebo-controlled,randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease.Int J Cardiovasc Intervent,2001,4:165-172.
  • 5Davignon J.Beneficial cardiovascular phiotropic effects of st-atins.Circulation,2004,109:Ⅲ,39-43.
  • 6Williams JK,Sukhova GK,Herrington DM,et al.Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.J Am Coll Cardiol.1998:684-691.
  • 7吕琳,罗静,鹿克风.氟伐他汀对实验性动脉粥样硬化家兔血管壁NF-κB表达的影响[J].心肺血管病杂志,2006,25(1):43-45. 被引量:9
  • 8Stefanadis C,Toutouzas K,Vavuranakis M,et al.Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques.Eur Heart J,2002:1664-1669.
  • 9Puccetti L,Bruni F,Bova G,et al.Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolcmic subjects.Nutr Metab Cardiovase Dis,2001,11:378-387.
  • 10赵卓,吴学思.他汀类药物在急性冠状动脉综合征中的抗炎地位[J].心肺血管病杂志,2005,24(1):58-60. 被引量:3

二级参考文献30

  • 1Thompson GR,Hollyer J,Waters DD.Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease.Curr Opin Lipidol,1995,6:386-388.
  • 2Jukema JW, Bruschke AVG, Boven AJ,et al.Effects of lipid lowering by provastatin on progression and regression of coronary heart disease in symptomatic men with normal to moderately elevated serum cholesterol levels:the Regression Growth Evaluation Statin Study(REGRESS).Circulation, 1995,91:2528-2540.
  • 3Moreno PR, Falk E, Palacios IF,et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation, 1994,90:775-778.
  • 4Idrissia A,Nicolas D,Claudio I,et al.C-Reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes.Am Heart J, 1999,137:346-351.
  • 5Lindahl B,Toss H,Siegbahn A,et al.Markers of myocardiol damage and inflammation inrelation to long term mortality in unstable coronary artery disease.FRISC study group.fragmin during instability in coronary artery disease. N Engl J Med,2000,343:1139.
  • 6Winter RJ.Independent Prognostic Value of C-reactive protein and troponin Iin patients with unstable angina of non-Q-wave myocardial Infarction.Cardiovasc Res, 1999,42:240-245.
  • 7Biasucci LM,Liuzzo G,Grillo RL,et al.Elevated levels of C-reactiva protein at discharge in patients with unstable angina predict recurrent instability.Circulation, 1999,99:855-860.
  • 8Ferreiros ER,Boissonnet CP,Pizarro R,et al.Independent prognostic value of elevated C-reactive protein in unstable angina.Circulation, 1999,100:1958-1963.
  • 9Becker RC,Cannon CP, Bovil EG,et al.Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q wave myocardial infarction.Am J Cardiol, 1996,78:142-147.
  • 10Libby P,Ridker PM, Maseri Attilio.Inflammation and atherosclerosis.Circulation, 2002,105:1135-1143.

共引文献10

同被引文献26

  • 1赵卓,吴学思.他汀类药物在急性冠状动脉综合征中的抗炎地位[J].心肺血管病杂志,2005,24(1):58-60. 被引量:3
  • 2王征,胡大一,杨进刚,李田昌,王阳.替罗非班对急性心肌梗死病人PCI术后炎性因子影响的观察[J].中国医药导刊,2006,8(5):330-332. 被引量:6
  • 3Rigatelli G,Giordan M,Candaioli Pet al.Lilac artery thrombosis after aortic ballon counterpulsation treatment with intmarterial tirofiban,mamnual thrombectomy and stenting[J].Int J Cardiol,2006,112(3):387-388.
  • 4Matsumoto H,Inoue N,Takaoka H,et al.Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction[J].Clin Cardio1,2004,27(8):466-470.
  • 5Pandor A,Ara RM,Tumur I,et al.Ezetimibe monotherapy forcholesterol lowering in 2,722 people:systematic review and me-ta-analysis of randomized controlled trials.J Intern Med,2009,265:568-580.
  • 6Thygesen K,Alpert JS,White HD,et al.Universal definition ofmyocardial infarction.J Circulation,2007,116:2634-2653.
  • 7Pearson TA,Ballantyne CM,Veltri E,et al.Pooled analyses ofeffects on C-reactive protein and low density lipoprotein cholester-ol in placebo-controlled trials of ezetimibe monotherapy orezetimibe added to baseline statin therapy.Am J Cardiol,2009,103:369-374.
  • 8Farnier M,Freeman MW,Macdonell G,et al.Efficacy and safe-ty of the coadministration of ezetimmibe with fenofibrate in pa-tients with mixed hyperlipidaemin.Eur Heart J,2005,26:897-905.
  • 9Baigent C,Landray MJ,Reith C,et al.The effects of loweringLDL cholesterol with simvastatin plus ezetimibe in patients withchronic kidney disease(Study of Heart and Renal Protection):a randomised placebo-controlled trial.Lancet,2011,377:2181-2192.
  • 10Pearson TA,Ballantyne CM,Veltri E,et al.Pooled analyses ofeffects on C-reactive protein and low density lipoprotein cholester-ol in placebo-controlled trials of ezetimibe monotherapy orezetimibe added to baseline statin therapy.Am J Cardiol,2009.103:369-374.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部